A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephanie Gaillard, MD
GOG Foundation
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
- Mount Sinai Medical Center
Miami Beach, Florida, United States
- Adventhealth Gynecologic Oncology
Orlando, Florida, United States
- Moffit Cancer Center at International Plaza
Tampa, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Moffit Cancer Center at Wesley Chapel
Wesley Chapel, Florida, United States
- Ascension St. Vincent
Indianapolis, Indiana, United States
- Norton Cancer Institute
Louisville, Kentucky, United States
- Johns Hopkins Medicine
Baltimore, Maryland, United States
- Northwell Health Cancer Institute
Lake Success, New York, United States
- Qcc- Northwell Health Physicians Partners Medical
Rego Park, New York, United States
- Kettering Health Cancer Center
Kettering, Ohio, United States
- Oklahoma Cancer Specialists and Research Institute, Llc
Tulsa, Oklahoma, United States
- Legacy Good Samaritan Medical Center
Portland, Oregon, United States
- Legacy Meridian Park Medical Center
Tualatin, Oregon, United States
- Legacy Salmon Creek Medical Center
Vancouver, Washington, United States
- University of Wisconsin Clinical Science Center
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Sept 2024
- Primary completion
- 1 May 2028
- Completion
- 1 Nov 2028
- Last update posted
- 3 Mar 2026
- Registered enrollment
- 51
- Registry id
- NCT05154487
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.